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Localization
PhosphorylationCdc6 is cleaved at residues 442 and 290 by caspase-3 during apoptosis producing p49-tCdc6 and p32-tCdc6, re-
spectively. While p32-tCdc6 is unable to translocate into the cytoplasm, p49-tCdc6 retains cytoplasmic translo-
cation activity, but it has a lower efﬁciency than wild-type Cdc6. We hypothesized that a novel nuclear export
signal (NES) sequence exists between amino acids 290 and 442. Cdc6 contains a novel NES in the region of
amino acids 300–315 (NES2) that shares sequence similarity with NES1 at residues 462–476. Inmutant versions
of Cdc6, we replaced leucinewith alanine in NES1 and NES2 and co-expressed themutant constructs with cyclin
A. We observed that the cytoplasmic translocation of these mutants was reduced in comparison to wild-type
Cdc6. Moreover, the cytoplasmic translocation of a mutant inwhich all four leucine residues were mutated to al-
anine was signiﬁcantly inhibited in comparison to the translocation of wild-type Cdc6. The Crm1 binding activ-
ities of Cdc6 NES mutants were consistent with the efﬁciency of its cytoplasmic translocation. Further studies
have revealed that L468 and L470 of NES1 are required for cytoplasmic translocation of Cdc6 phosphorylated
at S74, while L311 and L313 of NES2 accelerate the cytoplasmic translocation of Cdc6 phosphorylated at S54.
These results suggest that the two NESs of Cdc6 work cooperatively and distinctly for the cytoplasmic transloca-
tion of Cdc6 phosphorylated at S74 and S54 by cyclin A/Cdk2.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Cdc6, a component of the pre-replication complex, is required for
loading the MCM complex onto chromosomes to commence DNA repli-
cation initiation with ORC and Cdt1 during S phase of the cell cycle [1,2].
In yeast, as cells pass into S phase, Cdc6 is targeted for degradation by
SCFCDC4-dependent ubiquitination and is subsequently degraded by the
proteasome. Several mutations in consensus sites for Cdk phosphoryla-
tion at the N-terminus of Cdc6 in Sacchromyces pombe and Sacchromyces
cerevisiae inhibit degradation, indicating that phosphorylation triggers
this proteolysis [2]. In mammalian cells, phosphorylation of Cdc6 by
cyclin A/Cdk2 at the N-terminal consensus CDK phosphorylation sites
facilitates translocation of Cdc6 from the nucleus to the cytoplasm, thus
preventing re-initiation of replication during S and G2 phases [3,4]. The
conformational changes induced by phosphorylation of Cdc6 may un-
mask the C-terminal nuclear export signals (NES) required for nuclear
export [5–7]. Overexpression of a mutant form of Cdc6/Cdc18 lacking, a mutant version of Cdc6 with
of Cdc6 with S54A and S106A;
A; p49-tCdc6, a truncated Cdc6
cated Cdc6 at D290, producing
82 31 400 5958.
ights reserved.CDK phosphorylation sites leads to the nuclear accumulation of the pro-
tein [8,9]. Thus, chromosomal re-replication can be induced in the ab-
sence of cell division by a mechanism that involves preventing
cytoplasmic translocation of Cdc6 [10–12].
Cellular proteins containing both nuclear import and export signals
can shuttle between the nucleus and the cytoplasm. Cells can regulate
this dynamic movement and subsequently control the localization and
activity of individual proteins and protein complexes [13,14]. Nuclear
export signal (NES) sequences have been identiﬁed in many cellular
proteins. In the HIV-1 Rev protein, the NES motif comprises a minimal
11-amino acid peptide (LQLPPLERLTL), and mutations of critical leu-
cines abolish its export activity [15,16]. Functional NESs consist of a
core of closely spaced leucines or other large hydrophobic amino
acids. NESs have been detected in several very diverse cellular proteins
and function by directly binding to a nuclear export receptor called the
chromosomal region maintenance 1 (Crm1/exportin1) [17,18]. Cdc6 is
reported to have a NES in residues 462–488, which contains a core of
15 highly hydrophobic amino acid residues, ILVCSLMLLIRQLKI [5].
In earlier reports, we suggested that caspase-3-mediated cleavage of
Cdc6 disturbs the cytoplasmic localization of truncated Cdc6 and
induces apoptosis [6,19]. In addition, caspase-3-mediated cleavage of
Cdc6 generates two N-terminal Cdc6 truncation fragments, p49-tCdc6
and p32-tCdc6, which have lost the putative carboxy-terminal NES,
but are differentially retained in the nucleus [6]. Our recent study
showed that the phosphorylation site serine 74 is critical for the
224 I.S. Hwang et al. / Biochimica et Biophysica Acta 1843 (2014) 223–233transport of Cdc6 into the cytoplasm [7]. Interestingly, phosphorylation
at S54 also contributes to its localization in the cytoplasm, but phos-
phorylation at S106 does not [7].
Based on these previous studies, we hypothesized that Cdc6 con-
tains another NES sequence between amino acid residues 290 and
442, since p49-tCdc6 can still translocate into the cytoplasm by phos-
phorylation, albeit to a lesser extent than intact Cdc6 [6]. Furthermore,
nuclear export of p32-tCdc6 is more strongly inhibited, even when it
is phosphorylated at both S74 and S54 by cyclin A/Cdk2 [6,7]. Here,
we show that Cdc6 interacts with Crm1 and that Cdc6 contains two dis-
tinct NES motifs. The cytoplasmic translocation of Cdc6 is mediated by
interaction with Crm1 and the two NES motifs in the regions of amino
acids 300–315 and 462–476.We further demonstrate that the cytoplas-
mic translocation driven by phosphorylation of S54 or S74 of Cdc6 is
differentially regulated by two NES sequences.2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed Eagle's medium (DMEM) and calf serum were
purchased from Life Technologies, Inc. (Carlsbad, CA, USA). The trans-
fection reagent Polyfect® was purchased from Qiagen (Valencia, CA,
USA), and other chemical reagents were purchased from Sigma
(St. Louis, MO, USA).2.2. Plasmids
Human Cdc6 cDNA was kindly provided by Dr. R. S. Williams. For
mutation of the NES sequences, Leu 306, Leu 311, Leu 313, Leu 468,
and Leu 470 residues were converted to Ala by altering the Leu codons
GAT or GAC to Ala codons AAT or AAC, respectively. To generate chime-
ric E2F1, NES2 cDNAwas generated by PCR using 5′-GTTGAATTCAATGG
CCTTGGCCGGG-3′ (with added EcoRI site) and 5′-GAGGCCTGAAATCC
AGGGGGGTG-3′ (with added StuI site) and inserted into pCMV-HA-
E2F1 cDNA.2.3. Cell culture, transfection and imaging
Human cervical carcinoma (HeLa) cellsweremaintained at 37 °C and
5% CO2 as a monolayer culture in DMEM supplemented with 10% (v/v)
heat-inactivated calf serum, 100 units/mL penicillin, and 100 μg/mL
streptomycin. HeLa cells were seeded on 35-mm culture plates or slides
at a density of 5 × 104 cells/mL for 24 h before transfection with 3 μg of
the appropriate plasmids using Polyfect (Qiagen) according to the
manufacturer's instructions. For DAPI staining, cells were ﬁxed in 4%
paraformaldehyde solution (Sigma) for 10 min at room temperature
after transfection, treated with DAPI solution for 10 min at 37 °C, and
washed twice with PBS. Anti-HA polyclonal antibody was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Images were
made with a camera connected to a ﬂuorescence microscope (Nikon,
Eclipse Ti, Tokyo, Japan).2.4. Co-transfection
HeLa cells were transfected in 35-mm dishes with 1.5 μg of the ap-
propriate plasmids using 12 μL Polyfect according to themanufacturer's
instructions and harvested 24 h later in lysis buffer (0.5% Triton X-100,
20 mM Tris [pH 7.5], 2 mM MgCl2, 1 mM DTT, 1 mM EGTA, 50 mM
β-glycerophosphate, 25 mM NaF, 1 mM Na3VO4, 2 μg/mL leupeptin,
2 μg/mL pepstatin A, 100 μg/mL PMSF, 1 μg/mL antipain). Translocation
analysis of HeLa cells was performed 24 h after transfection using a
propidium iodide staining solution as described above.2.5. Preparation of nuclear and cytoplasmic cell extracts and immunoblot
analysis
Nuclear and cytoplasmic cell extractswere prepared from cells in lysis
buffer (10 mM HEPES [pH 7.4], 10 mM KCl, 2 mM MgCl2, 5 mM EGTA,
25 μg/mL leupeptin, 5 μg/mL pepstatin A, 1 mM phenyl methyl sulfonyl
ﬂuoride [PMSF], 40 mM β-glycerophosphate, 1 mM dithiothreitol
[DTT]). Nuclei were collected by centrifugation at 800 ×g for 10 min
through 30% sucrose (800 ×g, 10 min at 4 °C) and suspended in RIPA
buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
50 mM Tris [pH 8.0], 20 mM β-glycerophosphate, 50 mM NaF, 1 μg/mL
leupeptin, 1 μg/mL antipain, 1 μg/mL pepstatin A, 0.1 mM PMSF). The
cytosol was centrifuged at 100,000 ×g for 1 h, and the supernatant was
collected. For Western blot studies, nuclear lysates were centrifuged at
12,000 rpm for 15 min at 4 °C, and the supernatants were collected.
After adjusting the protein concentration (BCA assay, Pierce, Chester,
UK), cell lysateswere boiled and resolved by 12% SDS-PAGE beforeWest-
ern blot analysis with appropriate antibodies. An anti-Cdc6 monoclonal
antibody raised against full-length Cdc6 of human origin (sc-9964),
anti-p-S54-Cdc6 polyclonal (sc-12920-R), anti-pS74-Cdc6 polyclonal
(sc-12921-R), anti-Cdk2 polyclonal and anti-cyclin A monoclonal anti-
bodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The anti-ﬂag monoclonal antibody was from Upstate (New York,
NY, USA). Immune complexes were revealed using ECLTM Western blot-
ting detection reagents (GE Healthcare Life Sciences, Piscataway, NJ,
USA) and an Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, NE, USA).2.6. Immunoprecipitation assay
Crm1 was immunoprecipitated from tCdc6-overexpressing HeLa
cells using an anti-Crm1 polyclonal antibody (Santa Cruz) in buffer
(0.5% Triton X-100, 20 mM Tris pH 7.5, 2 mM MgCl2, 1 mM DTT,
1 mM EGTA, 50 mM β-glycerophosphate, 25 mM NaF, 1 mM Na3VO4,
2 μg/mL leupeptin, 2 μg/mL pepstatin A, 100 μg/mL PMSF, 1 μg/mL
antipain), followed by incubation with protein A agarose at 4 °C for
2 h. The samples were combined with protein A agarose, suspended
in SDS loading buffer, and resolved by SDS-PAGE.2.7. GST pull-down assay
Glutathione S-transferase (GST) fusion polypeptideswere expressed
in Escherichia coli strain BL17 and puriﬁed using immobilized
glutathione-sepharose4Bbeads (GEHealthcare Life Sciences) according
to the manufacturer's instructions. E. coli cells were lysed in lysis buffer
(25 mM HEPES [pH 7.5], 5 mM EDTA, 2 mM DTT, 0.1% CHAPS 1 mM
PMSF protease inhibitor cocktail). The GST fusion protein was puriﬁed
and conﬁrmed on SDS-polyacrylamide gels stained with Coomassie
blue. For preparation of Cdc6, GFP-tagged wild type Cdc6 and NES
mutants were expressed in HeLa cells. For afﬁnity chromatography of
transfectant GFP-tagged Cdc6 bound to GST-fusion polypeptides,
200 μg of the cell lysates was incubated with 40 μL GST-Crm1 resin
(50% slurry) in PBS buffer for 4 h at 4 °C. The resins were washed four
times with binding buffer, eluted with SDS-PAGE sample buffer, and
subjected to SDS-PAGE and Western blotting.2.8. FACS analysis
To observe cell cycle phase after treatment with hydroxyurea, cells
were collected by trypsinization, ﬁxed in 75% ethanol, stained with
500 μL of a 50 μg/mL propidium iodide solution, and subjected to
ﬂuorescence-activated cell sorting (FACS) analysis. Cells were sorted
and analyzed usingGuava Easy Cyte™ 8 andGuava Soft 2.2.3 (Millipore,
Billerica, MA, USA).
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Fig. 1. Endogenous Cdc6 interacts with Crm1 in S phase. (A) HeLa cells were treated with (HU) or without (Asy) 2.5 mM hydroxyurea for 24 h, and cells were harvested. Nuclear and
cytosolic cellular extracts were resolved by 10% SDS-PAGE and subjected to immunoblot analysis using anti-pS54-Cdc6, anti-pS74-Cdc6, anti-Cdc6, anti-cyclin E, anti-cyclin A, and
anti-actin antibodies. (B) HeLa cells were cotransfected with 1.5 μg wild-type Cdc6 plasmid along with pCMV empty vector (Control), cyclin A, cyclin E, or dominant negative Cdk2
(DN-Cdk2) plasmid. Cell extracts were prepared after 24 h, resolved by SDS-PAGE, and analyzed by immunoblot using anti-pS54-Cdc6, anti-pS74-Cdc6, anti-pS106-Cdc6, anti-Cdc6,
anti-cyclin E, anti-cyclin A, and anti-actin antibodies. (C–E) HeLa cells were treated with 2.5 mM hydroxyurea for 24 h and harvested at 0 h (HU) or at 3 h (HU-3) after release into
fresh medium. (C) Cell lysates were immunoprecipitated with an anti-Crm1 antibody (upper panel), and total cell lysates (lower panel) were resolved by 10% SDS-PAGE and subjected
to immunoblot analysis with anti-Cdc6, anti-phospho-Cdc6, anti-Crm1 and anti-actin antibodies. * is a non-speciﬁc band. (D) After immunoprecipitation as described in Fig. 1C, immuno-
blot analysiswas donewith anit-Crm1, anti-phospho-Cdc6, and anti-Cdc6 antibodies. (E) To determine the cell cycle phase, FACS analysiswas performed and analyzed as described in the
Materials and methods section. The percent of cells in each phase was analyzed and plotted (right panel).
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3.1. Cdc6 binds to Crm1 in HeLa cells
Phosphorylation at S74 of Cdc6 is the main contributor to cytoplas-
mic translocation, while phosphorylation at S54 affects cytoplasmic
translocation to a lesser extent [7]. Since overexpression of proteins
could alter the localization patterns, the location of endogenous Cdc6
was observed using immunochemistry and fractionation assay [7]. Con-
sistent with our previous report, endogenous Cdc6 phosphorylated at
S74 was observed in the cytosolic extract. Cdc6 phosphorylated at S54
was observed mainly in the nucleus and weakly in the cytoplasm in
hydroxyurea-treated cells containing relatively high levels of cyclin A
and cyclin E as compared to those of asynchronized cells (Fig. 1A). To
determine whether cyclin/CDK is the main factor contributing to phos-
phorylation at S74 and cytoplasmic translocation, we co-expressed
wild-type Cdc6 along with cyclin A or cyclin E in HeLa cells. Expression
of cyclin A resulted in the phosphorylation of Cdc6 at S74, the main
phosphorylation site for the cytoplasmic translocation [7], while
coexpression with cyclin E did not contribute signiﬁcantly to the phos-
phorylation of Cdc6 at S74 (Fig. 1B). These results suggest that phos-
phorylation of Cdc6 at S74 is mediated by cyclin A/CDK, which affects
cytoplasmic translocation.
We wanted to investigate whether the cytoplasmic translocation of
Cdc6 is associated with its interaction with Crm1, a receptor for
leucine-rich nuclear export. Previously, Jiang et al. showed that treat-
mentwith leptomycin B, a Crm1 inhibitor, blocked cytoplasmic translo-
cation of a phosphomimic mutant of Cdc6 [3]. However, an interaction
between Crm1 and Cdc6 was not directly observed in that study. Thus,
we performed immunoprecipitation with an anti-Crm1 antibody to
determine whether Cdc6 interacts with Crm1 for its cytoplasmic trans-
location (Fig. 1C). Cell lysates were prepared 3 h after release from the
hydroxyurea block for 24 h (HU-3); the results showed that Cdc6
interacted with Crm1 in hydroxyurea-treated HeLa cells (Fig. 1C).
Cells were in S phase after treatment with hydroxyurea, as determined
by FACS analysis (Fig. 1E). The interaction between Cdc6 and Crm1 sig-
niﬁcantly increased in hydroxyurea-treated cells comparedwith that of
control cells. We checked the phosphorylation status of Crm1-bound
Cdc6 by immunoprecipitation using an anti-Crm1 antibody and by
immunoblot using a speciﬁc phospho-Cdc6 antibody. Phosphorylation
at S74 and S54 of Crm1-bound Cdc6 was detected, but phosphorylation
at S106was not (Fig. 1D), indicating that Cdc6 phosphorylated at S74 or
S54 interacts with Crm1, which is possibly associatedwith the cytoplas-
mic translocation of Cdc6.
3.2. Crm1 interacts with wild-type Cdc6 and p49-tCdc6 but not with
p32-tCdc6
In a previous study, we found that Cdc6 was speciﬁcally cleaved
by caspase-3 to produce p49-tCdc6 andp32-tCdc6 fragments during ap-
optosis in etoposide-treatedHeLa cells [6].We further observed that the
cleavage of Cdc6 by caspase-3 induced nuclear accumulation of truncat-
ed Cdc6, with a greater retention of p32-tCdc6 than of p49-tCdc6. Hence
we hypothesized that Cdc6 may contain a novel NES between amino
acids 290 and 442. Endogenous Cdc6 is shown to bind to Crm1
(Fig. 1), an export receptor for leucine-rich NES.We examined whetherFig. 2. Crm1 interacts with Cdc6-wt and p49-tCdc6 but not with p32-tCdc6. (A–C) Cells were c
wild-type Cdc6 (Cdc6-wt), p49-tCdc6, or p32-tCdc6 together with 1.5 μg pCMV empty vector (
were ﬁxed with 4% paraformaldehyde and the nucleus was stained with DAPI. GFP-Cdc6 prote
panel shows the cotransfection efﬁcacy when pCMV-cyclin A (cyclin a; red) and pCS2 + GFP-C
cytoplasmic localization were determined; data are expressed as means ± standard deviations
counted in each experiment. (C) Cell extracts were prepared after 24 h, resolved by 10% SDS-PA
and anti-actin antibodies. (D)An in vitroGST-pull-down assaywas performedwith cell lysates t
(p49), or p32-tCdc6 (p32) as described in the Materials and methods section. Samples were re
Cdc6 antibodies to detect GST-Crm1 and Cdc6. (E) Cells were transfected with 1.5 μg pCS2 +
(p32). Cell extracts were prepared after 24 h, immunoprecipitated with anti-Crm1 and then ththe differential competence for nuclear export was associated with the
ability to interact with Crm1. Transfection studies showed that the
cytoplasmic translocation ofwild-type Cdc6 (Cdc6-wt)wasmarkedly in-
duced by approximately 94% by coexpression with cyclin A (Fig. 2A–C).
Under the same conditions, the cytoplasmic translocation of p49-tCdc6
was induced by 37%, a much lower extent than that observed with
Cdc6-wt. Moreover, the cytoplasmic translocation of p32-tCdc6 was
even lower, with 16% in cells coexpressing cyclin A (Fig. 2A and B). We
assessed whether the differential translocation competence of truncated
Cdc6 was correlated with the ability to interact with Crm1. We used an
in vitro GST-pull down assay to demonstrate that, consistent with the
results shown in Fig. 1C and D, wild-type Cdc6 strongly interacted
with Crm1 (Fig. 2D). In contrast, the interaction of GST-tagged Crm1
with truncated Cdc6 was signiﬁcantly reduced to a successively lower
extent with p49- and p32-tCdc6, while the levels of Crm1-unbound
p49-tCdc6 and p32-tCdc6 were reversibly increased when immuno-
blotting was performed with GST-bead-depleted supernatants
(Fig. 2D). The interaction between p32-tCdc6 and Crm1 was barely
detectable. We conﬁrmed our results through immunoprecipitation
with anti-Crm1 antibodies in cells expressing wild-type Cdc6,
p49-tCdc6, and p32-tCdc6 (Fig. 2E). Consistent with the in vitro
GST-pull down assay results, p32-tCdc6 was not detected as a binding
protein of Crm1, indicating that the differential loss of translocation
competence of truncated Cdc6 proteins was due to the loss of amino
acid sequences critical for interaction with Crm1. These results sug-
gested that Cdc6 may contain an additional NES sequence between
amino acid residues 290 and 442.
3.3. Cdc6 contains NESmotifs in the regions of amino acid residues 300–315
and 462–476 that contribute to cytoplasmic translocation mediated by
cyclin A/Cdk2-dependent phosphorylation
To test whether Cdc6 had an unidentiﬁed NES sequence between
amino acids 290 and 442 of Cdc6, we searched for a consensus
leucine-rich NES motif within a stretch of characteristically spaced
hydrophobic amino acids (Fig. 3A). Our analysis indicated that there
were two candidate NES-like sequences in 15–16 amino acid tracts
(residues 300–316 and 462–476), each of which includes a stretch of
leucine- or isoleucine-rich sequences. Comparison with human, mouse,
and Xenopus showed that these sequences were relatively conserved
(Fig. 3B). In leucine-rich NES sequences, the C-terminal leucine residues
are critical for NES activity (Fig. 3A). To validate the NES sequences of
Cdc6, the leucine residues at positions 311, 313, 468, and 470 were re-
placed with alanine residues to construct Cdc6 NES mutants named
NMT1 (NES1 mutant; L468/470A), NMT2 (NES2 mutant; L311/313A),
and NMT3 (double mutant of NES1 and NES2; L311/313/468/470A)
(Fig. 3C). The results from the transfection study indicated that cytoplas-
mic translocation of NMT2 and of NMT1wasmarkedly suppressed, even
when cyclin Awas coexpressed (Fig. 3D and E). The cytoplasmic localiza-
tion of NMT1 decreased by 35%, as comparedwith that ofwild-type Cdc6
in cells coexpressing cyclin A (Fig. 3D and E). The cytoplasmic localiza-
tion of NMT2 was also signiﬁcantly reduced by 20% in comparison to
wild-type Cdc6. Moreover, cytoplasmic localization of NMT3 was mark-
edly suppressed by up to 50% compared with that of wild-type Cdc6 in
cells cotransfected with pCMV-cyclin A. In pCMV control vector-
cotransfected cells, all versions of Cdc6 were primarily located in theotransfected with 1.5 μg pCS2 + GFP-tagged empty vector (Control), pCS2 + GFP-tagged
Ctrl) or pCMV-cyclin A (CyA), as indicated. (A) Twenty-four hours after transfection, cells
ins were observed by ﬂuorescence microscopy. The scale bar represents 20 μm. The lower
dc6 (Cdc6; green) were cotransfected. (B) The percentages of transfected cells exhibiting
from three determinations obtained in each of three experiments. At least 400 cells were
GE, and subjected to immunoblot analysis with anti-p-S54-Cdc6, anti-Cdc6, anti-cyclin A,
hat expressed pCS2 + GFP (Control), pCS2 + GFP-taggedwild-type Cdc6 (wt), p49-tCdc6
solved by 10% SDS-PAGE and subjected to immunoblot analysis with anti-Crm1 and anti-
GFP (Control), pCS2 + GFP-tagged wild-type Cdc6 (wt), p49-tCdc6 (p49), or p32-tCdc6
e interacting proteins were analyzed by immunoblot with anti-Cdc6.
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A-coexpressing cells under this condition, indicating that the mutation
of NES sequences did not affect the phosphorylation status of Cdc6
(Fig. 3F). Additionally, mutagenesis of isoleucine 314 and 316 wasGFP
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a GST-pull down assay was performed with GST-tagged Crm1 and
Cdc6-wt, NMT1, NMT2, or NMT3 (Fig. 3G). The results clearly indicated
that the ability of NMT1 and NMT2 to interact with Crm1 was signiﬁ-
cantly impaired as comparedwith wild-type Cdc6. Moreover, the inter-
action between NMT3 and Crm1wasmore impaired, as this interaction
was only weakly detected (Fig. 3G).
3.4. A new NES sequence of Cdc6 is identiﬁed in amino acid residues
300–315
To determinewhether the 300–315 sequence is a newNES signal, the
cytoplasmic translocation effect by nuclear location sequence (NLS) and
NES2 in the 300–315 regionwithoutNES1 sequence in residues 462–476
(Fig. 4A) was tested using deletion mutants. The mutant encompassed
amino acids 1–300 (mutant 300) has NLS and CDK-phosphorylation
sites at the N-terminus, but it does not have two NES regions (Fig. 4A),
whereas the mutant encompassed amino acids 1–324 (mutant 324)
has a novel NES (amino acids 300–315) additionally. When mutant of300 was expressed, it was located to the nucleus in control. When cyclin
A was coexpressed with mutant 300, the cytoplasmic translocation of
mutant 300 was markedly impaired (around 10.6%) compared with
that of wild type Cdc6 (around 93.5%). However, mutant 324 was local-
ized to the cytoplasm in 61.3% of cyclin A-coexpressing cells (Fig. 4B–D),
indicating that a novel nuclear export signal sequence resides in residues
300–315. As a negative control for the nuclear location signal and phos-
phorylation of Cdc6, the Δ110 mutant with a deletion of amino acids
1–110 (mutant Δ110) was expressed; very little nuclear localization
was seen with this mutant regardless of whether cyclin A was
coexpressed or not (Fig. 4B–C).
To conﬁrm that the 300–315 sequence is a new NES signal, the se-
quences of NES2 of Cdc6 (amino acid residues 310–315) were inserted
into a hemagglutinin (HA)-tagged E2F1 plasmid since E2F1, a transcrip-
tion factor, possesses an intrinsic nuclear localization signal [20,21]. The
locations of E2F1 and chimera E2F1–NES2 were determined by immu-
nochemistry using anti-HA antibody (Fig. 4E–F). Our results showed
that HA-tagged wild type E2F1 was mainly located in the nucleus as
expected, while chimeric E2F1 combined with NES2 was localized in
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that of chimeric E2F1 was 88.4% by combination with the NES2 regions
(Fig. 4E–F). To make clear whether NES2 functions as blocking import
into the nucleus or facilitating export to the cytoplasm, leptomycin B
an inhibitor of the nuclear export was treated to the cells expressing
E2F1–NES2 chimera or wild type of E2F1. The results show that chime-
ric E2F1–NES2 was dramatically translocated into the nuclei and cells
showing cytoplasmic location were decreased to around 6.0%, when
cells were treated with leptomycin B for 4 h. These data indicate that
the residues 300–315 functions as facilitating export to the cytoplasm
and the residues 300–315 is a novel NES.
Taken together, these results suggest that Cdc6 contains a novel NES
sequence in residues 300–315 in addition to the NES1 sequence inA
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3.5. The two NES motifs differentially mediate cytoplasmic translocation of
Cdc6 by cyclin A/Cdk2-depedent phosphorylation
The cytoplasmic translocation of Cdc6 is thought to require phos-
phorylation of three N-terminal serine residues (S54, S74, and S106)
by cyclin A/Cdk2 [3]. Recently, we found that phosphorylation of the
serine 74 residue of Cdc6 has a major effect on cytoplasmic transloca-
tion, while the phosphorylation of serine 54 of Cdc6 has only a minor
effect, and phosphorylation at S106 has no effect [7]. We wondered
whether the cytoplasmic translocation of Cdc6 is functionally associatedCtrl   CyA
2    ASA-NMT3
-NMT3
3A
468A 470A
3A 468A 470A
                                                    C560
                                                    C560
                                                    C560
                                                    C560
C
Pe
rc
en
t c
el
ls
 
sh
ow
in
g 
cy
to
pl
as
m
ic 
lo
ca
tio
n 
(%
)
80
60
40
20
0
Cyclin A
ASA    ASA-N1  ASA-N2  ASA-N3
NES1 in cyclin A-expressing HeLa cells. (A) Schematic representation of a phosphorylable
e mutation at serine residues S74 of Cdc6 was combined with alterations of the putative
S2 + GFP-tagged ASA mutant of Cdc6 (ASA), or NES mutant combined with ASA mutant
, as indicated. (B) Cells were ﬁxed for 24 h and stained with DAPI for DNA. The scale bar
ere determined. Data are expressed as means ± standard deviations from three determi-
nt. (D) Cell extracts were prepared after 24 h, resolved by 10% SDS-PAGE, and subjected to
.
Cyclin A
Cdc6
Actin
Ctrl CyA Ctrl CyA Ctrl CyA Ctrl CyA Ctrl   CyA
Control           SAA     SAA-NMT1   SAA-NMT2  SAA-NMT3
p-54S-Cdc6
A
B
D
SAA          SAA-NMT1     SAA-NMT2    SAA-NMT3
Cyclin A
GFP
DAPI
Merge
SAA
SAA-NMT1
SAA-NMT2
SAA-NMT3
54S   74A   106A
468A 470A54S   74A   106A
311A 313A 468A 470A
311A 313A54S   74A   106A
54S   74A   106A
N1                                                                                                            C560
N1                                                                                                            C560
N1                                                                                                            C560
N1                                                                                                            C560
40
30
20
10
0
SAA   SAA-N1  SAA-N2  SAA-N3
Cyclin A
Pe
rc
e
n
t c
e
lls
 
sh
ow
in
g 
cy
to
pl
as
m
ic 
lo
ca
tio
n 
(%
)
C
Fig. 6. Cytoplasmic translocation of Cdc6 associated with phosphorylation at S54 is functionally linked to NES2 mainly in cyclin A-expressing HeLa cells. (A) Schematic representation of
phosphorylablemutant at serine residues S54 andNESmutant versions of Cdc6proteins. The phosphorylablemutation at serine residues S54 of Cdc6was combinedwith alterations of the
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phosphorylation on S74 and/or S54. To investigate this, we constructed
eight mutant versions of Cdc6 in which mutated phosphorylation sites
at S54 or S74 were combined with NES1 and NES2 mutations. The ASA
(S54A and S106A) or SAA (S74A and S106A)mutation that allows phos-
phorylation on a single serine residue (S74 or S54, respectively) was
combined with the NES mutation NMT1 (NES1 mutant), NMT2 (NES2
mutant) and NMT3 (double NES1 and NES2 mutant) (Figs. 5A and 6A).
A transfection study showed that the cytoplasmic translocation of
the ASA mutant of Cdc6 was approximately 62% when cyclin A was
coexpressed. When an NES mutation was combined with the ASA
phosphomutant that was phosphorylated only at S74 by cyclin A/Cdk2,
cytoplasmic translocation was signiﬁcantly impaired by NMT1 but not
by NMT2 (Fig. 5B and C). Translocation of ASA–NMT1 and ASA–NMT3
decreased to 39% and 44%, respectively, while that of ASA–NMT2 was
not altered as compared with that of ASA (Fig. 5). The results of this
experiment indicated that the cytoplasmic translocation of ASA–NMT3,
a double NES mutant of ASA–Cdc6, was as suppressed as ASA–NMT1,the single NES1 mutant version of ASA–Cdc6. These results suggest
that phosphorylation of S74 of Cdc6 by cyclin A/Cdk2 is functionally
associated with NES1-dependent cytoplasmic translocation of Cdc6
(Fig. 5B and C).
The results of the transfection study with the SAA, SAA–NMT1,
SAA–NMT2 and SAA–NMT3 mutants suggested that phosphorylation at
S54 is primarily linked to the NES2-dependent translocation of Cdc6
(Fig. 6B–C). SAA showed 32% translocation into the cytoplasm when cy-
clin A was coexpressed, implying that phosphorylation at S54 was a
minor contributor to the cytoplasmic translocation in comparison to
phosphorylation at S74. Under the same conditions, cytoplasmic translo-
cation of SAA–NMT1 and SAA–NMT2decreased to around 20% and 5%, re-
spectively, by combinationwith the SAA andNMT regions, indicating that
phosphorylation of S54 by cyclin A/Cdk2 was more functionally linked to
NES2-dependent cytoplasmic translocation of Cdc6. The cytoplasmic
translocation of SAA–NMT3 was around 2%, which was lower than that
of SAA–NMT2.We also testedwhether coexpression of cyclin Awould re-
sult in the phosphorylation of these mutant versions of Cdc6 on S54
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(Control), pCS2 + GFP-tagged Cdc6-wt (WT), DDS mutant (S54D and S74D), or AAS
mutant (S54A and S74A). (A) Cell extracts were prepared after 24 h, resolved by 10%
SDS-PAGE, and subjected to immunoblot analysis using speciﬁc antibodies to Crm1,
Cdc6, GFP, and actin. Expression levels of proteins were observed by Western blot.
(B) Cell lysates were immunoprecipitated with an anti-Crm1 antibody, resolved by 10%
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tein to interact with ectopically expressed GFP-tagged Cdc6-wt or mutants in HeLa cells.
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phospho-Cdc6 antibody on serine 54 showed that the SAA mutants
were similarly phosphorylated on S54 in cyclin A-coexpressing cells.
Taken together, these results indicate that the two NES motifs, NES1
and NES2, are functionally linked to the cytoplasmic translocation of
Cdc6 protein and that the NES1- and NES2-dependent translocations of
Cdc6 are differentially regulated by the phosphorylation on S74 and S54
of Cdc6, respectively.
4. Discussion
Cdc6, a DNA replication factor, plays an essential role in the assembly
of prereplication complexes at the origin and in theﬁring of DNA replica-
tion initiation [2]. Cdc6 has been reported to have other important func-
tions in checkpoint induction after DNA replication has started [22,23]
and in maintenance of the ATR-ATRIP (Rad3–Rad26) complex on chro-
matin for blocking the onset of mitosis [22–24]. In apoptosis, Cdc6 is
cleaved by caspase-3 at aspartate residues 442 and 290, producing trun-
cated proteinswithmolecularweights of 49 kDa and 32 kDa, respective-
ly [6,19,25]. The truncated forms of Cdc6 accelerate etoposide-induced
apoptosis, and the ectopic expression of truncated Cdc6 (tCdc6) itself
induces apoptosis. In this study, we suggested that the tCdc6-induced
effect on apoptosis correlates well with the loss of ability to be exported
from the nucleus. p49-tCdc6, but not p32-tCdc6, is translocated into the
cytoplasm, although the extent of translocation of p49-tCdc6 is much
lower than that of Cdc6-wt in cyclin A-coexpressing cells [6]. Thus, we
proposed that p49-tCdc6 contains a novel NES motif between amino
acid residues 290 and 442. An earlier report based on deletion mutants
of Cdc6 suggested that there may be an NES sequence between amino
acid residues 462 and 488 near the C-terminus [5]. A study of the fate
of cellular Cdc6 and its subcellular behavior during apoptotic cell death
is expected to provide important information for understanding the
mechanisms that regulate its subcellular levels and function. Here, we
identiﬁed a novel NES2motif in amino acid residues 300–315 in addition
to NES1 at the C-terminus (amino acid residues 462–476) in Cdc6.
Further, we demonstrated that NES1 and NES2 differentially mediate
cytoplasmic translocation regulated by phosphorylated serine 74 and
54 residues, respectively.
The NES motif is characterized by hydrophobic amino acids and a
short leucine-rich region that is speciﬁcally recognized by the nuclear ex-
porter protein Crm1 [14]. Our study also showed that the interaction of
Cdc6 with Crm1 appears to be induced in hydroxyurea-treated cells
(Fig. 1C and D). The interaction of Cdc6with Crm1 accordingly decreases
as Cdc6 undergoes proteolytic cleavage into p49-tCdc6 and p32-tCdc6
fragments, indicating that these truncations eliminate theNES sequences
necessary for Crm1 binding (Fig. 2D). This idea is supported by observa-
tion that the cytoplasmic translocation and Crm1-binding abilities of
p49-tCdc6 are markedly decreased by further cleavage to p32-tCdc6
(Fig. 2). Moreover, the interactions of Crm1 with NES mutants, NMT1
and NMT2, were signiﬁcantly disrupted as compared with that of
Cdc6-wt, even though the Cdk2-phosphorylation sites S54 and S74
were phosphorylated. These results indicate that both NES1 and NES2
are critical for Crm1 binding (Fig. 3). Furthermore, Crm1 binding to the
NES double mutant NMT3 was further impaired in comparison to the
Crm1 binding to the single NESmutants, NMT1 andNMT2. The impaired
binding abilities of the NES mutants correlate very well with their re-
duced cytoplasmic translocation (Fig. 3). However, mutation of both
NES1 and NES2 sequences (NMT3) did not fully disturb cytoplasmic
translocation (Fig. 3). We observed that 42% of NMT3 still translocated
into the cytosol, likely because the Crm1-binding activities of the NES
mutants NMT1 and NMT2 are not completely abolished by substituting
alanine for the L468 and L470 residues in NES1 and L311 and L313 in
NES2. This is consistent with the idea that the double mutant NMT3
can still interact with Crm1, although its binding activity is much lower
than that of NMT1 and NMT2 (Fig. 3E). Nevertheless, the results clearly
indicate that NES1 and NES2 are functionally linked to the cytoplasmictranslocation of Cdc6 that is mediated by interacting with Crm1 in cyclin
A-coexpressing cells.
The contributing effect of NES1 to Cdc6 cytoplasmic translocation is
higher than that of NES2 under conditions that allow the phosphorylation
of S54 and S74, since the cytoplasmic translocation of NMT1 was more
disturbed than that of NMT2 (See Fig. 3). The contributions of NES1 to
translocation are far greater than those of NES2 when only S74 is phos-
phorylated (Fig. 5). Under conditions that allow the phosphorylation of
S54 alone, the contributing effect of NES2 is higher than that of NES1,
even though the phosphorylation of S54 regulates the cytoplasmic trans-
location of only a minor portion of Crm-1 (Fig. 6). These results indicate
that the Crm1-binding activity of Cdc6, which is mediated by NES1, is
largely regulated by phosphorylation of S74, while the binding activity
that is mediated by NES2 is regulated by S54 phosphorylation. Thus, we
suggest that phosphorylation at S74 and S54 of Cdc6 by cyclin A/Cdk2 is
required for its cytoplasmic translocation, which is mediated through
the cooperative actions of NES1 and NES2 for Crm1-mediated nuclear
export.
233I.S. Hwang et al. / Biochimica et Biophysica Acta 1843 (2014) 223–233How does the phosphorylation of Cdc6 affect NES- and Crm1-
mediated cytoplasmic translocation? We hypothesized that the phos-
phorylation of Cdc6 occurs at the N-terminal serine 54 and 74 residues
by cyclin A/Cdk2may induce a conformational change that exposes the
C-terminal NES of Cdc6. These conformational changes may accelerate
the interaction between Cdc6 andCrm1. To determine this,we observed
the interactions between Crm1 and a phosphomutant of Cdc6 (see
Fig. 7). DDS is a phospho-mimic mutant of Cdc6, whereas AAS is an
unphospho-mimic mutant of Cdc6 at serines 54 and 74. Our results in-
dicated that the interactionwith Crm1was not much different between
wild type and mutant Cdc6 indicating that the phosphorylation status
did not affect the binding afﬁnity to Crm1.
The serine 74 and 54 residues of Cdc6 are located in themiddle of or
near the nuclear localization signal (NLS) between amino acids 56–58
and 80–95 [5], but the serine 106 residue is not located nearby. Thus,
it is possible that the phosphorylation of serines 74 and 54 of Cdc6
near the NLS could disrupt the activity of the NLS through suppression
of the interaction between NLS of Cdc6 and shuttling proteins, such as
importin [26]. Phosphorylation at S74 and S54 may provide a balance
of activity of NLS and NES and it may affect the environmental condi-
tions near the NLS and NES, which sequentially affect subcellular local-
ization. Another possibility is that a third factor acting as a mediator for
nuclear export could be involved in the complex of Crm1 and Cdc6, and
its recruitment could be increased as a result of phosphorylation of
Cdc6, whichmay accelerate the nuclear export of Cdc6. How this mech-
anism functions is an open question for further study.
Phosphorylation is an important event for the regulation of nuclear
export by alteration of the environmental conditions between trans-
porter and nucleocytoplasmic shuttling proteins [27,28]. For example,
phosphorylation of Smad-3 in the linker region mediated by CDKs and
MAPKs results in cytoplasmic translocation, consequently turning off
the TGF-beta effect [29]. In addition, several cellular regulatory factors
including HDAC7, PPAR, p27KIP, and p21CIP are transported to the nucle-
us after phosphorylation by PKD1, casein kinase II, hKIS and by Akt or
PKC, respectively [27,28,30,31]. Phosphorylation is affected not only
by nuclear export but also by nuclear import [28]. Thus, phosphoryla-
tion is a pivotal regulatorymechanism for nucleocytoplasmic trafﬁcking
of cellular proteins.Acknowledgements
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